Dr. Zhu and Dr. Gosselin receive NIH funding

May 15, 2018

Using the multiple PI funding mechanisms, Dr. Xiaoping Zhu and Dr. Edmund Gosselin in the Albany Medical School receive an NIH R21 grant ($447,252) that will develop an adjuvant-free mucosal vaccine.  This platform technology will be tested using a highly significant infectious disease model, which will lay the foundation for future testing and clinical development of this adjuvant-free vaccine and its eventual use against an array of current, emerging, and re-emerging pathogens.